JunAP

N/A

Report date: 2024/04/30 13:15:37
NMEFirst In Class

Base Information

Drug NameJunAP
Drug Alias NameJunAP
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTranscription factor AP1 inhibitors
TargetsTranscription factor AP1
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSapience Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSapience Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A